ReviewGenomics & informatics2013
Current status, challenges, policies, and bioethics of biobanks.
Review in Genomics & informatics, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 36 citations in OpenAlex.
- Extending Specimens to Save Plant DNA: Structuring Department DNA Collections in Times of Biodiversity Loss.Ecology and evolution · 2026Article
- Barriers and opportunities in biobank utilization: insights from a 3-year repeated cross-sectional survey of the Female Breast and Genital Disease with Microbiome Biobank Network in South Korea.Journal of Yeungnam medical science · 2025Article
- Online survey on existing sarcoidosis registries and biobanks: an ERN lung initiative.Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG · 2024Article
- A scoping review of considerations and practices for benefit sharing in biobanking.BMC medical ethics · 2021Article
- Harmonization of Biobank Education for Biobank Technicians: Identification of Learning Objectives.Biotech (Basel (Switzerland)) · 2021Article
- Willingness of women to participate in obstetrical and pediatric research involving biobanks.Journal of community genetics · 2020Article
- Bioinformatics in Mexico: A diagnostic from the academic perspective and recommendations for a public policy.PloS one · 2020Article
- An Introduction to Starting a Biobank.Methods in molecular biology (Clifton, N.J.) · 2019Review
- Aspects of Modern Biobank Activity - Comprehensive Review.Pathology oncology research : POR · 2018Review
- Article
- Assessing Researcher Needs for a Virtual Biobank.Biopreservation and biobanking · 2017Article
- Design and implementation of a mobile system for lung cancer patient follow-up in China and initial report of the ongoing patient registry.Oncotarget · 2017Article
- The Geisinger MyCode community health initiative: an electronic health record-linked biobank for precision medicine research.Genetics in medicine : official journal of the American College of Medical Genetics · 2016Article
- ESR Position Paper on Imaging Biobanks.Insights into imaging · 2015Article
- To Share or Not to Share? A Survey of Biomedical Researchers in the U.S. Southwest, an Ethnically Diverse Region.PloS one · 2015Article
- A Multidisciplinary Biospecimen Bank of Renal Cell Carcinomas Compatible with Discovery Platforms at Mayo Clinic, Scottsdale, Arizona.PloS one · 2015Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Many biobanks were established as biorepositories for biomedical research, and a number of biobanks were founded in the 1990s. The main aim of the biobank is to store and to maintain biomaterials for studying chronic disease, identifying risk factors of specific diseases, and applying personalized drug therapies. This report provides a review of biobanks, including Korean biobanks and an analysis of sample volumes, regulations, policies, and ethical issues of the biobank. Until now, the top 6 countries according to the number of large-scale biobanks are the United Kingdom, United States, Sweden, France, the Netherlands, and Italy, and there is one major National Biobank of Korea (NBK) and 17 regional biobanks in Korea. Many countries have regulations and guidelines for the biobanks, and the importance of good management of biobanks is increasing. Meanwhile, according to a first survey of 456 biobank managers in the United States, biobankers are concerned with the underuse of the samples in their repositories, which need to be advertised for researchers. Korea Biobank Network (KBN) project phase II (2013-2015) was also planned for the promotion to use biospecimens in the KBN. The KBN is continuously introducing for researchers to use biospecimens in the biobank. An accreditation process can also be introduced for biobanks to harmonize collections and encourage use of biospecimens in the biobanks. KBN is preparing an on-line application system for the distribution of biospecimens and a biobank accreditation program and is trying to harmonize the biobanks.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.